AGT and heart failure: In addition to their effects on blood pressure (4, 5), vasoconstrictor peptides, such as angiotensin II (AngII) and endothelin−1 (ET1), appear to be important contributors to the progression of heart failure following STEMI via non-hemodynamic pathways that lead to adverse myocardial remodeling.